In the past week, HSCS stock has gone up by 18.81%, with a monthly decline of 0.00% and a quarterly plunge of -4.99%. The volatility ratio for the week is 6.89%, and the volatility levels for the last 30 days are 7.47% for Heart Test Laboratories Inc. The simple moving average for the last 20 days is 11.39% for HSCS stock, with a simple moving average of -65.97% for the last 200 days.
Is It Worth Investing in Heart Test Laboratories Inc. (NASDAQ: HSCS) Right Now?
Moreover, the 36-month beta value for HSCS is 3.39. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HSCS is 54.96M and currently, short sellers hold a 0.25% of that float. On April 24, 2024, HSCS’s average trading volume was 1.50M shares.
HSCS) stock’s latest price update
Heart Test Laboratories Inc. (NASDAQ: HSCS) has seen a rise in its stock price by 21.33 in relation to its previous close of 0.10. However, the company has experienced a 18.81% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-02 that Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on Tuesday April 9, 2024 at 5:00pm ET at the Sofitel New York. Mr. Simpson will also be hosting one-on-one meetings through the conference.
HSCS Trading at 2.07% from the 50-Day Moving Average
After a stumble in the market that brought HSCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.91% of loss for the given period.
Volatility was left at 7.47%, however, over the last 30 days, the volatility rate increased by 6.89%, as shares surge +0.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.51% lower at present.
During the last 5 trading sessions, HSCS rose by +18.81%, which changed the moving average for the period of 200-days by -86.89% in comparison to the 20-day moving average, which settled at $0.1077. In addition, Heart Test Laboratories Inc. saw -29.82% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HSCS
Current profitability levels for the company are sitting at:
- -1.17 for the present operating margin
- 0.46 for the gross margin
The net margin for Heart Test Laboratories Inc. stands at -1.24. The total capital return value is set at -0.66. Equity return is now at value -152.61, with -89.51 for asset returns.
Based on Heart Test Laboratories Inc. (HSCS), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -6.04. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -16.41.
Currently, EBITDA for the company is -6.08 million with net debt to EBITDA at 1.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.38. The receivables turnover for the company is 351.26for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.71.
Conclusion
To wrap up, the performance of Heart Test Laboratories Inc. (HSCS) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
